ESMO 2025 | Understanding occupational exposure in chemotherapy administration
Karen Campbell, PhD, Edinburgh Napier University, Edinburgh, UK, discusses findings highlighting the pathways of chemotherapy contamination within clinical environments. She emphasizes that contamination can originate in the pharmacy and spread into nursing units, underscoring the importance of shared awareness and responsibility across multidisciplinary teams. Dr Campbell advocates for continual education and enhanced use of personal protective equipment (PPE) to mitigate exposure risks, stressing that maintaining ongoing vigilance and knowledge of contamination sources is critical for ensuring staff safety in oncology care settings. This interview took place at the European Society for Medical Oncology (ESMO) 2025 Congress in Berlin, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
